Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio HoldingsTSE:6092 +1.11%58 Current Ratio is 2.20 as of Mar. 2026, which is 22% above its 10-year median of 1.81. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円799.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,092 Business Services companies, EnBio Holdings ranks better than 60.9% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. EnBio Holdings's current ratio for the quarter that ended in Mar. 2026 was 2.20.
EnBio Holdings has a current ratio of 2.20. It generally indicates good short-term financial strength.
The historical rank and industry rank for EnBio Holdings's Current Ratio or its related term are showing as below:
TSE:6092'
s Current Ratio Range Over the Past 10 Years
Min: 1.4 Med: 1.81 Max: 2.2
Current: 2.2
During the past 13 years, EnBio Holdings's highest Current Ratio was 2.20. The lowest was 1.40. And the median was 1.81.
TSE:6092's Current Ratio is ranked better than 60.9% of 1092
companies
in the Business Services industry
Industry Median: 1.83
vs TSE:6092: 2.20
EnBio Holdings (TSE:6092) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
EnBio Holdings Current Ratio Related Terms
EnBio Holdings Current Ratio Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, ULS: Current Ratio Comparison
For the Specialty Business Services subindustry, EnBio Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings Current Ratio vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings (TSE:6092) has a Current Ratio of 2.20 as of Mar. 2026. This is 22% above median its historical median of 1.81. Over the past decade, EnBio Holdings' Current Ratio has ranged from 1.40 to 2.20. According to the industry distribution chart, EnBio Holdings ranks #427 out of 1092 companies in the Business Services industry, placing it in the top 39.1%.
Is EnBio Holdings' Current Ratio too high?
EnBio Holdings' current Current Ratio of 2.20 is 22% above median its 10-year median of 1.81. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 2.20. The Business Services industry median Current Ratio is 1.83. EnBio Holdings' value of 2.20 is 20.2% above this industry median. Based on the distribution chart, EnBio Holdings ranks #427 out of 1092 companies in the Business Services industry, which is above the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Current Ratio compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #427 out of 1092 companies for Current Ratio. This puts EnBio Holdings in the upper half of its industry. The industry median Current Ratio is 1.83. EnBio Holdings' value of 2.20 is 20.2% above this benchmark. Historically, EnBio Holdings' own Current Ratio has ranged from 1.40 to 2.20 over the past decade. While the company's 10-year median is 1.81 vs. the industry median of 1.83, EnBio Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Business Services company?
The median Current Ratio among Business Services companies is 1.83, based on 1,092 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current Current Ratio of 2.20 is 20.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Business Services industry, the median Current Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current Current Ratio is 2.20, which is 22% above median its own 10-year median of 1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円799.37, compared to a current price of 円728.00 — trading 8.9% below its estimated fair value. The current Current Ratio is 2.20, which is 22% above median its 10-year median of 1.81 and 20.2% above the Business Services industry median of 1.83. EnBio Holdings' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Current Ratio is 2.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued.
The current stock price of 円728.00 is trading 8.9% below its estimated GF Value™ of 円799.37.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
Current Ratio: 2.20 (22% above median its 10-year median of 1.81)
GF Value™: 円799.37 vs. price of 円728.00 (8.9% below fair value)
Industry Position: 20.2% above the Business Services median (#427 of 1092)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
